市場調査レポート

商品コード

1737061

先進創傷治療市場：先進創傷治療製品タイプ別、先進創傷治療創傷被覆材タイプ別、バイオエンジニアリング皮膚・真皮代替物タイプ別、創傷治癒医療機器タイプ別、創傷治療タイプ別、エンドユーザータイプ別、主要地域別市場

Advanced Wound Care Market Distribution by Type of Advanced Wound Care Product, Type of Advanced Wound Care Dressing, Type of Wound Healing Medical Device, Type of End User and Key Geographical Regions

出版日: 2025年05月26日
発行: Roots Analysis
ページ情報: 英文 255 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,799 690,240円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (One-Location Site License)

USD 6,999 1,006,666円

レポートPDFを同一所在地における特定事業ユニットに属する全ての方にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Department License)

USD 10,599 1,524,454円

レポートPDFを部署単位で12名様までご利用いただけるライセンスです。同一部署内であれば、地理的に同じ地点に存在する必要はありません。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 17,999 2,588,796円

レポートPDFを同社の国内外拠点における全ての方にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.83円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の先進創傷治療の市場規模は、2035年までの予測期間中に5.20%のCAGRで拡大し、現在の115億7,000万米ドルから2035年までに202億1,000万米ドルに成長すると予測されています。

市場セグメンテーションでは、市場規模および機会分析を以下のパラメータで区分しています：

先進創傷治療製品タイプ別

先進創傷治療用ドレッシング
バイオエンジニアリング皮膚と真皮代替物
創傷治癒医療機器

先進創傷治療創傷被覆材タイプ別

フォームドレッシング
抗菌ドレッシング材
ハイドロゲルドレッシング
ハイドロコロイド・ドレッシング
アルジネートドレッシング
複合ドレッシング材
その他

バイオエンジニアリング皮膚・真皮代替物タイプ別

同種移植片
自家移植
細胞外マトリックス
成長因子
その他の皮膚代替物

創傷治癒医療機器タイプ別

陰圧創傷治療
高気圧酸素療法
局所酸素療法
水処理
電気刺激療法
皮膚閉鎖システム／接着剤
その他の創傷治癒医療機器

創傷タイプ別

急性創傷
慢性創傷

急性創傷タイプ別

手術創
火傷
その他の急性創傷

慢性創傷タイプ別

静脈性潰瘍
糖尿病性潰瘍
褥瘡
その他の慢性創傷

エンドユーザータイプ

病院でのケア
在宅ケア/ドアツードアサービス
その他

主要地域別

北米
欧州
アジア太平洋およびその他の地域

先進創傷治療市場：成長と動向

慢性疾患の増加により、創傷、精神疾患、血管障害、感覚障害などの併存疾患が増加しています。その中でも、創傷の管理はヘルスケア分野で重要な局面を迎えています。現在、世界中で1,500万人以上の人々がさまざまなタイプの創傷に苦しんでおり、310億米ドル以上のヘルスケア支出が生じています。米国だけでも、メディケア受給者は年間500億米ドル以上を創傷治療と管理に費やしています。経済的な影響だけでなく、創傷管理は生理学的な健康面にも負担を強います。例えば、創傷があるとQOL（生活の質）が2.5％低下します。創傷や慢性疾患にかかりやすい高齢者人口の増加に伴い、創傷管理はヘルスケア分野で最も重要な焦点となっています。このような課題を克服するために、複数の企業が先進的な創傷治療製品を開発し、現在も開発を続けています。

さらに、先進的な創傷治療製品の採用を増やすため、利害関係者は創傷治療製品を自動化ツール、人工知能、機械学習と積極的に統合しています。こうした取り組みにより、スマート包帯やモバイル操作可能な創傷治療製品の開発が進んでいます。その結果、創傷治療市場は今後数年で広く普及すると予想されます。

先進創傷治療市場：主要インサイト

当レポートでは、先進創傷治療市場の現状を掘り下げ、業界内の潜在的な成長機会を特定しています。主な調査結果は以下の通り：

現在、180社以上の企業が様々なタイプの先進創傷治療製品を製造していると主張しており、そのうち60％以上が北米に本社を置いています。
先進創傷治療製品を製造する企業の43％が先進創傷治療用ドレッシング材を提供しており、これらの企業の約85％が急性創傷と慢性創傷の両方に対応するドレッシング材を提供しています。
競合優位性を構築するため、各社はそれぞれの提供製品を強化し、進化する業界ベンチマークに準拠するため、既存の能力を積極的に拡大しています。
2018年以降、様々な先進的創傷治療製品の有効性を評価するために135以上の臨床試験が登録されており、これらの試験の50％は米国の様々な施設で実施されています。

ここ数年、この領域ではパートナーシップの活動が大きく伸びており、取引の大半は米国に拠点を置く企業別買収でした。
慢性創傷の有病率の上昇と老年人口の増加に牽引され、先進創傷治療製品市場は今後大きな成長を遂げると思われます。
先進創傷治療市場はCAGR 5.20％で成長すると予測されており、長期的には収益の大半は先進創傷治療用ドレッシング材を製造する企業別もたらされると思われます。

予測される市場機会は、創傷治癒医療機器の種類、治療される創傷の種類、主要地域別十分に分散されると予想されます。

先進創傷治療市場：主要セグメント

先進創傷治療製品タイプ別では、市場は先進創傷治療製品、創傷治療ドレッシング材、生体工学的皮膚・真皮代替物、創傷治癒医療機器に区分されます。現在、創傷治療用ドレッシング材分野が世界の先進創傷治療市場で最大（～60％）のシェアを占めています。さらに、生体工学的皮膚および皮膚代替物セグメントは、他のセグメントと比較して速いペースで成長すると思われます。

先進創傷治療創傷被覆材タイプ別では、市場はフォームドレッシング、抗菌ドレッシング、アルギン酸ドレッシング、ハイドロゲルドレッシング、ハイドロコロイドドレッシング、複合ドレッシング、その他の創傷被覆材に区分されます。現在、フォームドレッシング分野は世界の先進創傷治療市場で最も高い割合（～30％）を占めています。複合ドレッシング材セグメントの先進創傷治療市場は、比較的高いCAGRで成長する可能性が高いことは注目に値します。

バイオエンジニアリング皮膚・真皮代替物タイプ別では、市場は同種移植片、自家移植片、細胞外マトリックス、成長因子、その他の真皮代替物に区分されます。現在、先進創傷治療市場では同種移植片分野が最大シェア（～50％）を占めています。さらに、異種移植片、組織構築物、バイオエンジニアリング皮膚製品の承認が見込まれることから、細胞外マトリックス分野は相対的に高いCAGRで成長すると思われます。

創傷治癒医療機器タイプ別では、市場は陰圧創傷治療、高気圧酸素療法、局所酸素療法、水処理、電気刺激療法、その他の創傷治癒医療機器に区分されます。現在、陰圧創傷治療分野が先進創傷治療市場で最も高い割合（～50％）を占めています。さらに、局所酸素療法の先進創傷治療市場は比較的高いCAGRで成長する可能性が高いことも注目に値します。

創傷治療タイプ別では、市場は急性創傷と慢性創傷に区分されます。現在、慢性創傷分野が世界の先進創傷治療市場の最大シェア（~80%）を占めています。この動向は今後も変わらないと思われます。

治療対象の急性創傷タイプ別では、市場は手術創、熱傷、その他の急性創傷に区分されます。現在、外科創傷分野が先進創傷治療市場で最大のシェアを占めています。また、火傷分野は予測期間中に最も高い成長が見込まれ、他の分野と比較して高いCAGR（7.0%）で成長すると予測されています。

治療対象の慢性創傷タイプ別では、市場は糖尿病性潰瘍、褥瘡、静脈性潰瘍、その他の慢性創傷に区分されます。静脈性潰瘍セグメントが市場全体の主な促進要因になると予想される一方で、褥瘡セグメントの先進創傷治療世界市場のCAGRは6.5%と比較的高い成長が見込まれることは注目に値します。

エンドユーザー別に見ると、世界市場は病院ケア、在宅/ドア・ツー・ドアサービス、その他のエンドユーザーに区分されます。現在、病院ケア分野が最大の市場シェア（~50%）を占めています。しかし、在宅ケア/戸別訪問サービス向けの先進創傷治療市場は、今後数年間で大幅な成長が見込まれています。

主要地域別に見ると、市場は北米、欧州、アジア太平洋、その他の地域に区分されます。現在、北米（45％）が先進創傷治療市場を独占し、最大の収益シェアを占めています。

当レポートでは、世界の先進創傷治療市場について調査し、市場の概要とともに、先進創傷治療製品タイプ別、先進創傷治療創傷被覆材タイプ別、バイオエンジニアリング皮膚・真皮代替物タイプ別、創傷治癒医療機器タイプ別、創傷治療タイプ別、エンドユーザータイプ別、主要地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 6.1 Advanced Wound Care Products Manufacturers: Information on Year of Establishment, Company Size, Location of Headquarters and Type of Product Offered
Table 6.2 Advanced Wound Care Product Manufacturers: Information on Type of Wound Care Dressing
Table 6.3 Wound Care Dressing Manufacturers: Information on Type of Wound Treated
Table 6.4 Bioengineered Skins and Dermal Substitutes Manufacturers: Information on Type of Bioengineered Skin and Dermal Substitute
Table 6.5 Bioengineered Skins and Dermal Substitutes Manufacturers: Information on Type of Wound Treated
Table 6.6 Wound Healing Medical Device Manufacturers: Information on Type of Wound Healing Medical Device
Table 6.7 Wound Healing Medical Device Manufacturers: Distribution by Type of Wound Treated
Table 8.1 Advanced Wound Care Products Manufacturers: List of Companies Profiled
Table 8.2 3M: Company Overview
Table 8.3 3M: Advanced Wound Care Portfolio
Table 8.4 3M: Recent Developments and Future Outlook
Table 8.5 Coloplast: Company Overview
Table 8.6 Coloplast: Advanced Wound Care Portfolio
Table 8.7 Coloplast: Recent Developments and Future Outlook
Table 8.8 Ethicon (a subsidiary of Johnson & Johnson): Company Overview
Table 8.9 Ethicon (a subsidiary of Johnson & Johnson): Advanced Wound Care Portfolio
Table 8.10 Fidia Farmaceutici: Company Overview
Table 8.11 Fidia Farmaceutici: Advanced Wound Care Portfolio
Table 8.12 Molnlycke Health Care: Company Overview
Table 8.13 Molnlycke Health Care: Advanced Wound Care Portfolio
Table 8.14 Molnlycke Health Care: Recent Developments and Future Outlook
Table 8.15 Smith+Nephew: Company Overview
Table 8.16 Smith+Nephew: Advanced Wound Care Portfolio
Table 8.17 Smith+Nephew: Recent Developments and Future Outlook
Table 8.18 Zimmer Biomet: Company Overview
Table 8.19 Zimmer Biomet: Advanced Wound Care Portfolio
Table 8.20 Smith+Nephew: Recent Developments and Future Outlook
Table 8.21 Advanced Wound Care Manufacturers: List of Companies Profiled (Tabulated Profiles)
Table 8.22 Advanced Medical Solutions: Company Overview
Table 8.23 Advanced Medical Solutions: Advanced Wound Care Portfolio
Table 8.24 Arthrex: Company Overview
Table 8.25 Arthrex: Advanced Wound Care Portfolio
Table 8.26 Cardinal Health: Company Overview
Table 8.27 Cardinal Health: Advanced Wound Care Portfolio
Table 8.28 Convatec: Company Overview
Table 8.29 Convatec: Advanced Wound Care Portfolio
Table 8.30 DeRoyal: Company Overview
Table 8.31 DeRoyal: Advanced Wound Care Portfolio
Table 8.32 Essity: Company Overview
Table 8.33 Essity: Advanced Wound Care Portfolio
Table 8.34 Integra Life Sciences: Company Overview
Table 8.35 Integral Life Sciences: Advanced Wound Care Portfolio
Table 8.36 Medline Industries: Company Overview
Table 8.37 Medline Industries: Advanced Wound Care Portfolio
Table 8.38 Organogenesis: Company Overview
Table 8.39 Organogenesis: Advanced Wound Care Portfolio
Table 8.40 RTI Surgical: Company Overview
Table 8.41 RTI Surgical: Advanced Wound Care Portfolio
Table 10.1 Advanced Wound Care: List of Partnerships and Collaborations
Table 12.1 Advanced Wound Care Market: Distribution by Leading Companies
Table 23.1 Advanced Wound Care Manufacturers: Distribution by Year of Establishment
Table 23.2 Advanced Wound Care Manufacturers: Distribution by Company Size
Table 23.3 Advanced Wound Care Manufacturers: Distribution by Location of Headquarters (Region)
Table 23.4 Advanced Wound Care Manufacturers: Distribution by Location of Headquarters (Country)
Table 23.5 Advanced Wound Care Manufacturers: Distribution by Year of Establishment and Location of Headquarters (Region)
Table 23.6 Advanced Wound Care Product Manufacturers: Distribution by Type of Advanced Wound Care Products
Table 23.7 Wound Care Dressing Manufacturers: Distribution by Type of Wound Care Dressing
Table 23.8 Wound Care Dressing Manufacturers: Distribution by Type of Wound Treated
Table 23.9 Wound Care Dressing Manufacturers: Distribution by Type of Acute Wound Treated
Table 23.10 Wound Care Dressing Manufacturers: Distribution by Type of Chronic Wound Treated
Table 23.11 Bioengineered and Dermal Substitute Manufacturers: Distribution by Type of Bioengineered Skin and Dermal Substitute
Table 23.12 Bioengineered Skin and Dermal Substitute Manufacturers: Distribution by Type of Wound Treated
Table 23.13 Bioengineered Skin and Dermal Substitute Manufacturers: Distribution by Type of Acute Wound Treated
Table 23.14 Bioengineered Skin and Dermal Substitute Manufacturers: Distribution by Type of Chronic Wound Treated
Table 23.15 Wound Healing Medical Device Manufacturers: Distribution by Type Wound Healing Medical Device
Table 23.16 Wound Healing Medical Device Manufacturers: Distribution by Type Wound Treated
Table 23.17 Wound Healing Medical Device Manufacturers: Distribution by Type Acute Wound Treated
Table 23.18 Wound Healing Medical Device Manufacturers: Distribution by Type Chronic Wound Treated
Table 23.19 3M: Annual Revenues, FY 2018 Onwards (USD Billion)
Table 23.20 Coloplast: Annual Revenues, FY 2018 Onwards (DKK Billion)
Table 23.21 Johnson & Johnson: Annual Revenues, FY 2018 Onwards (USD Billion)
Table 23.22 Fidia Farmaceutici: Annual Revenues, FY 2018 Onwards (EUR Million)
Table 23.23 Molnlycke Healthcare: Annual Revenues, FY 2018 Onwards (EUR Billion)
Table 23.24 Smith + Nephew: Annual Revenues FY 2018 Onwards (USD Billion)
Table 23.25 Zimmer Biomet: Annual Revenues, FY 2018 Onwards (USD Billion)
Table 23.26 Clinical Trial Analysis: Cumulative Year-wise Trend
Table 23.27 Clinical Trial Analysis: Distribution of Trial Registration Year and Enrolled Patient Population
Table 23.28 Clinical Trial Analysis: Distribution by Trial Phase
Table 23.29 Clinical Trial Analysis: Distribution by Trial Phase and Enrolled Patient Population
Table 23.30 Clinical Trial Analysis: Distribution by Trial Status
Table 23.31 Clinical Trial Analysis: Distribution by Trial Status and Trial Registration Year
Table 23.32 Clinical Trial Analysis: Distribution by Type of Wound Treated
Table 23.33 Clinical Trial Analysis: Distribution by Type of Wound Care Product
Table 23.34 Clinical Trial Analysis: Distribution by Trial Focus Area
Table 23.34 Clinical Trial Analysis: Distribution by Trial Focus Area
Table 23.35 Clinical Trial Analysis: Distribution by Age Group of Enrolled Patients
Table 23.36 Clinical Trial Analysis: Distribution by Type of Sponsor / Collaborator
Table 23.37 Most Active Players: Distribution by Number of Clinical Trials
Table 23.38 Clinical Trial Analysis: Distribution of Clinical Trials by Geography
Table 23.39 Clinical Trial Analysis: Distribution by Trial Registration Year and Geography
Table 23.40 Clinical Trial Analysis: Distribution of Patients Enrolled by Geography
Table 23.41 Partnerships and Collaborations: Cumulative Year-Wise Trend
Table 23.42 Partnerships and Collaborations: Distribution by Type of Partnership
Table 23.43 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 23.44 Partnerships and Collaborations: Distribution by Purpose of Partnership
Table 23.45 Partnerships and Collaborations: Distribution by Type of Partner
Table 23.46 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Table 23.47 Most Active Players: Distribution by Number of Partnerships
Table 23.48 Partnerships and Collaboration: Local and International Agreements
Table 23.49 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Table 23.50 Advanced Wound Care Market, Historical Trends (Since 2019) (USD Billion)
Table 23.51 Advanced Wound Care Market, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.52 Advanced Wound Care Market: Distribution by Type of Advanced Wound Care Product
Table 23.53 Advanced Wound Care Market for Wound Care Dressings, Historical Trends (Since 2019) (USD Billion)
Table 23.54 Advanced Wound Care Market for Wound Care Dressings, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.55 Advanced Wound Care Market for Bioengineered Skins and Dermal Substitutes, Historical Trends (Since 2019) (USD Billion)
Table 23.56 Advanced Wound Care Market for Bioengineered Skins and Dermal Substitutes, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.57 Advanced Wound Care Market for Wound Healing Medical Devices, Historical Trends (Since 2019) (USD Billion)
Table 23.58 Advanced Wound Care Market for Wound Healing Medical Devices, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.59 Advanced Wound Care Market: Distribution by Type of Wound Care Dressing
Table 23.60 Advanced Wound Care Market for Foam Dressings, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.61 Advanced Wound Care Market for Antimicrobial Dressings, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.62 Advanced Wound Care Market for Hydrogel Dressings, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.63 Advanced Wound Care Market for Hydrocolloid Dressings, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.64 Advanced Wound Care Market for Alginate Dressings, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.65 Advanced Wound Care Market for Composite Dressings, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.66 Advanced Wound Care Market for Other Types of Wound Care Dressings, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.67 Advanced Wound Care Market: Distribution by Type of Bioengineered Skin and Dermal Substitute
Table 23.68 Advanced Wound Care Market for Allografts, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.69 Advanced Wound Care Market for Autografts, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.70 Advanced Wound Care Market for Extracellular Matrices, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.71 Advanced Wound Care Market for Growth Factors, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.72 Advanced Wound Care Market for Other Dermal Substitutes, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.73 Advanced Wound Care Market: Distribution by Type of Wound Healing Medical Device
Table 23.74 Advanced Wound Care Market for Negative Pressure Wound Therapy, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.75 Advanced Wound Care Market for Topical Oxygen Therapy, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.76 Advanced Wound Care Market for Hyperbaric Oxygen Therapy, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.77 Advanced Wound Care Market for Hydrotherapy, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.78 Advanced Wound Care Market for Electric Stimulation Therapy, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.79 Advanced Wound Care Market for Other Types of Wound Healing Medical Devices, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.80 Advanced Wound Care Market: Distribution by Type of Wound Treated
Table 23.81 Advanced Wound Care Market for Acute Wounds, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.82 Advanced Wound Care Market for Chronic Wounds, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.83 Advanced Wound Care Market: Distribution by Type of Acute Wound Treated
Table 23.84 Advanced Wound Care Market for Surgical Wounds, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.85 Advanced Wound Care Market for Burns, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.86 Advanced Wound Care Market for Other Types of Acute Wounds, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.87 Advanced Wound Care Market: Distribution by Type of Chronic Wound Treated
Table 23.88 Advanced Wound Care Market for Venous Ulcers, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.89 Advanced Wound Care Market for Diabetic Ulcers, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.90 Advanced Wound Care Market for Pressure Ulcers, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.91 Advanced Wound Care Market for Other Types of Chronic Wounds, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.92 Advanced Wound Care Market: Distribution by Type of End User
Table 23.93 Advanced Wound Care Market for Hospital Care, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.94 Advanced Wound Care Market for Home Care / Door to Door Services, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.95 Advanced Wound Care Market for Other Types of End Users, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion
Table 23.96 Advanced Wound Care Market: Distribution by Key Geographical Regions
Table 23.97 Advanced Wound Care Market in North America, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.98 Advanced Wound Care Market in the US, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.99 Advanced Wound Care Market in Canada, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.100 Advanced Wound Care Market in Europe, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.101 Advanced Wound Care Market in Germany, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.102 Advanced Wound Care Market in France, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.103 Advanced Wound Care Market in the UK, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.104 Advanced Wound Care Market in Italy, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.105 Advanced Wound Care Market in Spain, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.106 Advanced Wound Care Market in Asia-Pacific and Rest of the World, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.107 Advanced Wound Care Market in China, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.108 Advanced Wound Care Market in Japan, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.109 Advanced Wound Care Market in Brazil, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.110 Advanced Wound Care Market in Australia, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.111 Advanced Wound Care Market in South Korea, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 23.112 Advanced Wound Care Market in Israel, Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)

List of Figures

Figure 2.1 Research Methodology: Project Methodology
Figure 2.2 Research Methodology: Forecast Methodology
Figure 2.3 Research Methodology: Robust Quality Control
Figure 2.4 Research Methodology: Key Market Segmentations
Figure 3.1 Lessons Learnt from Past Recessions
Figure 4.1 Executive Summary: Advanced Wound Care Product Manufacturers Landscape
Figure 4.2 Executive Summary: Clinical Trial Analysis
Figure 4.3 Executive Summary: Partnerships and Collaborations
Figure 4.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 5.1 Types of Wounds and Injuries
Figure 5.2 Types of Advanced Wound Care Dressings
Figure 5.3 Types of Bioengineered Skins and Dermal Substitutes
Figure 5.4 Types of Wound Healing Medical Devices
Figure 6.1 Advanced Wound Care Product Manufacturers: Distribution by Year of Establishment
Figure 6.2 Advanced Wound Care Product Manufacturers: Distribution by Company Size
Figure 6.3 Advanced Wound Care Product Manufacturers: Distribution by Location of Headquarters (Region)
Figure 6.4 Advanced Wound Care Product Manufacturers: Distribution by Location of Headquarters (Country)
Figure 6.5 Advanced Wound Care Product Manufacturers: Distribution by Year of Establishment and Location of Headquarters
Figure 6.6 Advanced Wound Care Product Manufacturers: Distribution by Type of Advanced Wound Care Product
Figure 6.7 Wound Care Dressing Manufacturers: Distribution by Type of Wound Care Dressing
Figure 6.8 Wound Care Dressing Manufacturers: Distribution by Type of Wound Treated
Figure 6.9 Wound Care Dressing Manufacturers: Distribution by Type of Acute Wound Treated
Figure 6.10 Wound Care Dressing Manufacturers: Distribution by Type of Chronic Wound Treated
Figure 6.11 Bioengineered Skin and Dermal Substitute Manufacturers: Distribution by Type of Bioengineered Skin and Dermal Substitute
Figure 6.12 Bioengineered Skin and Dermal Substitute Manufacturers: Distribution by Type of Wound Treated
Figure 6.13 Bioengineered Skin and Dermal Substitute Manufacturers: Distribution by Type of Acute Wound Treated
Figure 6.14 Bioengineered Skin and Dermal Substitute Manufacturers: Distribution by Type of Chronic Wound Treated
Figure 6.15 Advanced Wound Care Manufacturers: Distribution by Type of Wound Healing Medical Device
Figure 6.16 Wound Healing Medical Devices Manufacturers: Distribution by Type of Wound Treated
Figure 6.17 Wound Healing Medical Device Manufacturers: Distribution by Type of Acute Wound Treated
Figure 6.18 Wound Healing Medical Devices Manufacturers: Distribution by Type of Chronic Wound Treated
Figure 7.1 Company Competitiveness Analysis: Wound Care Dressings Manufacturers in North America
Figure 7.2 Company Competitiveness Analysis: Wound Care Dressings Manufacturers in Europe
Figure 7.3 Company Competitiveness Analysis: Wound Care Dressings Manufacturers in Asia-Pacific and Rest of the World
Figure 7.4 Company Competitiveness Analysis: Bioengineered Skins and Dermal Substitutes Manufacturers in North America
Figure 7.5 Company Competitiveness Analysis: Bioengineered Skins and Dermal Substitutes Manufacturers in Europe, Asia-Pacific and Rest of the World
Figure 7.6 Company Competitiveness Analysis: Wound Healing Medical Devices Manufacturers in North America
Figure 7.7 Company Competitiveness Analysis: Wound Healing Medical Devices Manufacturers in Europe, Asia-Pacific and Rest of the World
Figure 8.1 3M: Annual Revenues, FY 2018 Onwards (USD Billion)
Figure 8.2 Coloplast: Annual Revenues, FY 2018 Onwards (DKK Billion)
Figure 8.3 Johnson & Johnson: Annual Revenues, FY 2018 Onwards (USD Billion)
Figure 8.4 Fidia Faramaceutici: Annual Revenues, FY 2018 Onwards (EUR Million)
Figure 8.5 Molnlycke Healthcare: Annual Revenues, FY 2018 Onwards (EUR Billion)
Figure 8.6 Smith+Nephew: Annual Revenues, FY 2018 Onwards (USD Billion)
Figure 8.7 Zimmer Biomet: Annual Revenues, FY 2018 Onwards (USD Billion)
Figure 9.1 Clinical Trial Analysis: Cumulative Year-wise Trend
Figure 9.2 Clinical Trial Analysis: Distribution of Trial Registration Year and Enrolled Patient Population
Figure 9.3 Clinical Trial Analysis: Distribution by Trial Phase
Figure 9.4 Clinical Trial Analysis: Distribution by Trial Phase and Enrolled Patient Population
Figure 9.5 Clinical Trial Analysis: Distribution by Trial Status
Figure 9.6 Clinical Trial Analysis: Distribution by Trial Status and Enrolled Patient Population
Figure 9.7 Clinical Trial Analysis: Distribution by Type of Wound Treated
Figure 9.8 Clinical Trial Analysis: Distribution by Type of Wound Care Product
Figure 9.9 Clinical Trial Analysis: Distribution by Trial Purpose
Figure 9.10 Clinical Trial Analysis: Distribution by Age Group of Enrolled Patients
Figure 9.11 Clinical Trial Analysis: Distribution by Type of Sponsor / Collaborator
Figure 9.12 Most Active Players: Distribution by Number of Clinical Trials
Figure 9.13 Clinical Trial Analysis: Distribution of Clinical Trials by Geography
Figure 9.14 Clinical Trial Analysis: Distribution by Trial Registration Year and Geography
Figure 9.15 Clinical Trial Analysis: Distribution of Patients Enrolled by Geography
Figure 10.1 Partnerships and Collaborations: Cumulative Year-Wise Trend
Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 10.4 Partnerships and Collaborations: Distribution by Purpose of Partnership
Figure 10.5 Partnerships and Collaborations: Distribution by Type of Partner
Figure 10.6 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Figure 10.7 Most Active Players: Distribution by Number of Partnerships
Figure 10.8 Partnerships and Collaboration: Local and International Agreements
Figure 10.9 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Figure 11.1 Advanced Wound Care: Market Drivers
Figure 11.2 Advanced Wound Care: Market Restraints
Figure 11.3 Advanced Wound Care: Market Opportunities
Figure 11.4 Advanced Wound Care: Market Challenges
Figure 12.1 Global Advanced Wound Care Market, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 12.2 Global Advanced Wound Care Market, Forecasted Estimates (Till 2035): Conservative Scenario (USD Billion)
Figure 12.3 Global Advanced Wound Care Market, Forecasted Estimates (Till 2035): Optimistic Scenario (USD Billion)
Figure 13.1 Advanced Wound Care Market: Distribution by Type of Advanced Wound Care Product
Figure 13.2 Advanced Wound Care Market for Wound Care Dressings, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 13.3 Advanced Wound Care Market for Bioengineered Skins and Dermal Substitutes, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 13.4 Advanced Wound Care Market for Wound Healing Medical Devices, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 14.1 Advanced Wound Care Market: Distribution by Type of Wound Care Dressing
Figure 14.2 Advanced Wound Care Market for Foam Dressings, Forecasted Estimates (Till 2035) (USD Billion)
Figure 14.3 Advanced Wound Care Market for Antimicrobial Dressings, Forecasted Estimates (Till 2035) (USD Billion)
Figure 14.4 Advanced Wound Care Market for Alginate Dressings, Forecasted Estimates (Till 2035) (USD Billion)
Figure 14.5 Advanced Wound Care Market for Hydrogel Dressings, Forecasted Estimates (Till 2035) (USD Billion)
Figure 14.6 Advanced Wound Care Market for Hydrocolloid Dressings, Forecasted Estimates (Till 2035) (USD Billion)
Figure 14.7 Advanced Wound Care Market for Composite Dressings, Forecasted Estimates (Till 2035) (USD Billion)
Figure 14.8 Advanced Wound Care Market for Other Types of Wound Care Dressings, Forecasted Estimates (Till 2035) (USD Billion)
Figure 15.1 Advanced Wound Care Market: Distribution by Type of Bioengineered Skins and Dermal Substitute
Figure 15.2 Advanced Wound Care Market for Allografts, Forecasted Estimates (Till 2035) (USD Billion)
Figure 15.3 Advanced Wound Care Market for Autografts, Forecasted Estimates (Till 2035) (USD Billion)
Figure 15.4 Advanced Wound Care Market for Extracellular Matrices, Forecasted Estimates (Till 2035) (USD Billion)
Figure 15.5 Advanced Wound Care Market for Growth Factors, Forecasted Estimates (Till 2035) (USD Billion)
Figure 15.6 Advanced Wound Care Market for Other Dermal Substitutes, Forecasted Estimates (Till 2035) (USD Billion)
Figure 16.1 Advanced Wound Care Market: Distribution by Type of Wound Healing Medical Device
Figure 16.2 Advanced Wound Care Market for Negative Pressure Wound Therapy, Forecasted Estimates (Till 2035) (USD Billion)
Figure 16.3 Advanced Wound Care Market for Topical Oxygen Therapy, Forecasted Estimates (Till 2035) (USD Billion)
Figure 16.4 Advanced Wound Care Market for Hyperbaric Oxygen Therapy, Forecasted Estimates (Till 2035) (USD Billion)
Figure 16.5 Advanced Wound Care Market for Hydrotherapy, Forecasted Estimates (Till 2035) (USD Billion)
Figure 16.6 Advanced Wound Care Market for Electric Stimulation Therapy, Forecasted Estimates (Till 2035) (USD Billion)
Figure 16.7 Advanced Wound Care Market for Skin Closure Systems / Adhesives, Forecasted Estimates (Till 2035) (USD Billion)
Figure 16.8 Advanced Wound Care Market for Other Types of Wound Healing Medical Devices, Forecasted Estimates (Till 2035) (USD Billion)
Figure 17.1 Advanced Wound Care Market: Distribution by Type of Wound Treated
Figure 17.2 Advanced Wound Care Market for Acute Wounds, Forecasted Estimates (Till 2035) (USD Billion)
Figure 17.3 Advanced Wound Care Market for Chronic Wounds, Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.1 Advanced Wound Care Market: Distribution by Type of Acute Wound Treated
Figure 18.2 Advanced Wound Care Market for Surgical Wounds, Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.3 Advanced Wound Care Market for Burns, Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.4 Advanced Wound Care Market for Other Types of Acute Wounds, Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.1 Advanced Wound Care Market: Distribution by Type of Chronic Wound Treated
Figure 19.2 Advanced Wound Care Market for Diabetic Ulcers, Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.3 Advanced Wound Care Market for Venous Ulcers, Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.4 Advanced Wound Care Market for Pressure Ulcers, Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.5 Advanced Wound Care Market for Other Types of Chronic Wounds, Forecasted Estimates (Till 2035) (USD Billion)
Figure 20.1 Advanced Wound Care Market: Distribution by Type of End User
Figure 20.2 Advanced Wound Care Market for Hospital Care, Forecasted Estimates (Till 2035) (USD Billion)
Figure 20.3 Advanced Wound Care Market for Home Care / Door to Door Services, Forecasted
Figure 21.1 Advanced Wound Care Market: Distribution by Key Geographical Region
Figure 21.2 Advanced Wound Care Market in North America, Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.3 Advanced Wound Care Market in the US, Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.4 Advanced Wound Care Market in Canada, Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.5 Advanced Wound Care Market in Europe, Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.6 Advanced Wound Care Market in Germany, Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.7 Advanced Wound Care Market in France, Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.8 Advanced Wound Care Market in the UK, Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.9 Advanced Wound Care Market in Spain, Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.10 Advanced Wound Care Market in Italy, Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.11 Advanced Wound Care Market in Asia-Pacific and Rest of the World, Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.12 Advanced Wound Care Market in China, Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.13 Advanced Wound Care Market in Japan, Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.14 Advanced Wound Care Market in Brazil, Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.15 Advanced Wound Care Market in Australia, Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.16 Advanced Wound Care Market in South Korea, Forecasted Estimates (Till 2035) (USD Billion)
Figure 21.17 Advanced Wound Care Market in Israel, Forecasted Estimates (Till 2035) (USD Billion)
Figure 22.1 Conclusion: Advanced Wound Care Market Landscape
Figure 22.2 Conclusion: Clinical Trial Analysis
Figure 22.3 Conclusion: Partnerships and Collaborations
Figure 22.4 Conclusion: Market Sizing and Opportunity Analysis (I/II)
Figure 22.5 Conclusion: Market Sizing and Opportunity Analysis (II/II)

Product Code: RA100478

ADVANCED WOUND CARE MARKET: OVERVIEW

As per Roots Analysis, the global advanced wound care market is estimated to grow from USD 11.57 billion in the current year to USD 20.21 billion by 2035, at a CAGR of 5.20% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Advanced Wound Care Product

Advanced Wound Care Dressings
Bioengineered Skins and Dermal Substitutes
Wound Healing Medical Devices

Type of Advanced Wound Care Dressing

Foam Dressings
Antimicrobial Dressings
Hydrogel Dressings
Hydrocolloid Dressings
Alginate Dressings
Composite Dressings
Other Type of Wound Care Dressings

Type of Bioengineered Skins and Dermal Substitute

Allografts
Autografts
Extracellular Matrices
Growth Factors
Other Dermal Substitutes

Type of Wound Healing Medical Device

Negative Pressure Wound Therapy
Hyperbaric Oxygen Therapy
Topical Oxygen Therapy
Hydrotherapy
Electric Stimulation Therapy
Skin Closure Systems / Adhesives
Other Wound Healing Medical Devices

Type of Wound Treated

Acute Wounds
Chronic Wounds

Type of Acute Wound Treated

Surgical Wounds
Burns
Other Acute Wounds

Type of Chronic Wound Treated

Venous Ulcers
Diabetic Ulcers
Pressure Ulcers
Other Chronic Wounds
Type of End Users
Hospital Care
Home Care / Door to Door Services
Other Types of End Users

Key Geographical Regions

North America
Europe
Asia-Pacific and Rest of the World

ADVANCED WOUND CARE MARKET: GROWTH AND TRENDS

The rising prevalence of chronic diseases has resulted in an increase in the associated co-morbidities, including wounds, mental health disorders, vascular disorders, sensory impairments, and others. Among these, the management of wounds has emerged as a critical aspect within the healthcare sector. Presently, more than 15 million individuals worldwide are suffering from various types of wounds, generating a healthcare expenditure of more than USD 31 billion. In the US alone, Medicare beneficiaries spend more than USD 50 billion annually on wound treatment and management. Apart from the economic implications, wound management also imposes a burden on the physiological aspects of health. For instance, individuals experience a decline in quality of life by 2.5% due to the presence of associated wounds. With the rise in the geriatric population, which is prone to wounds and chronic disease conditions, the management of wounds has emerged as a paramount focal point within the healthcare sector. Several companies have developed and are developing advanced wound care products to overcome these challenges.

Further, in order to increase the adoption of advanced wound care products, stakeholders are actively integrating wound care products with automation tools, artificial intelligence and machine learning. These initiatives have led to the development of smart bandages and mobile-operated wound care products. Consequently, the wound care market is expected to gain widespread popularity in the coming years.

ADVANCED WOUND CARE MARKET: KEY INSIGHTS

The report delves into the current state of the advanced wound care market and identifies potential growth opportunities within the industry. Some key findings from the report include:

Currently, more than 180 companies claim to manufacture various types of advanced wound care products; of these, more than 60% of players are headquartered in North America.
43% of companies manufacturing advanced wound care products offer advanced wound care dressings; around 85% of these companies offer dressings to treat both acute and chronic wounds.
In pursuit of building a competitive edge, companies are actively expanding their existing capabilities to enhance their respective offerings and comply with evolving industry benchmarks.
Since 2018, over 135 clinical trials have been registered to evaluate the efficacy of various advanced wound care products; 50% of these studies are being conducted across different sites in the US.

In recent years, the domain has witnessed a significant growth in partnership activity; majority of the deals involved acquisitions by players located in the US.
Driven by the rising prevalence of chronic wounds and a growing number of geriatric populations, the market for advanced wound care products is poised to witness significant growth in the foreseen future.
The advanced wound care market is projected to grow at a CAGR of 5.20%; in the long term, the majority of the revenues are likely to be generated by players manufacturing advanced wound care dressings.

The projected market opportunity is anticipated to be well-distributed across different types of wound-healing medical devices, types of wounds treated and key geographical regions.

ADVANCED WOUND CARE MARKET: KEY SEGMENTS

Wound Care Dressings Segment Occupy the Largest Share of the Advanced Wound Care Market

Based on the type of advanced wound care product, the market is segmented into advanced wound care products, wound care dressings, bioengineered skin and dermal substitutes, and wound healing medical devices. At present, the wound care dressings segment holds the maximum (~60%) share of the global advanced wound care market. Additionally, the bioengineered skins and dermal substitutes segment is likely to grow at a faster pace compared to the other segments.

By Type of Advanced Wound Care Dressing, Composite Dressings is the Fastest Growing Segment of the Global Advanced Wound Care Market During the Forecast Period

Based on the type of advanced wound care dressing, the market is segmented into foam dressings, antimicrobial dressings, alginate dressings, hydrogel dressings, hydrocolloid dressings, composite dressings and other types of wound care dressings. Currently, the foam dressings segment captures the highest proportion (~30%) of the global advanced wound care market. It is worth highlighting that the advanced wound care market for the composite dressings segment is likely to grow at a relatively higher CAGR.

Allografts Segment Occupies the Largest Share of the Advanced Wound Care Market by Type of Bioengineered Skin and Dermal Substitute

Based on the type of bioengineered skin and dermal substitute, the market is segmented into allografts, autografts, extracellular matrices, growth factors and other dermal substitutes. At present, the allografts segment holds the maximum share (~50%) of the advanced wound care market. In addition, the anticipated approvals of xenografts, tissue constructs, and bioengineered skin products will likely drive the extracellular matrices segment to grow at a relatively higher CAGR.

By Type of Wound Healing Medical Devices, the Topical Oxygen Therapy Segment is the Fastest Growing Segment of the Advanced Wound Care Market During the Forecast Period

Based on the type of wound healing medical devices, the market is segmented into negative pressure wound therapy, hyperbaric oxygen therapy, topical oxygen therapy, hydrotherapy, electric stimulation therapy and other wound healing medical devices. Currently, negative pressure wound therapy segment captures the highest proportion (~50%) of the advanced wound care market. Further, it is worth highlighting that the advanced wound care market for topical oxygen therapy is likely to grow at a relatively higher CAGR.

Chronic Wounds Segment Account for the Largest Share of the Global Advanced Wound Care Market

Based on the type of wound treated, the market is segmented into acute wounds and chronic wounds. Currently, chronic wounds segment holds the maximum share (~80%) of the global advanced wound care market. This trend is likely to remain the same in the coming years.

By the Type of Acute Wound Treated, the Surgical Wounds Segment is Likely to Dominate the Advanced Wound Care Market

Based on the type of acute wound treated, the market is segmented into surgical wounds, burns and other acute wounds. At present the surgical wounds segment holds the maximum share of the advanced wound care market. Additionally, the burns segment is expected to show the highest growth potential during the forecast period, growing at a higher CAGR (7.0%), compared to the other segments.

The Venous Ulcers Segment by Type of Chronic Wound Treated Occupies the Largest Share of the Advanced Wound Care Market

Based on the type of chronic wound treated, the market is segmented into diabetic ulcers, pressure ulcers, venous ulcers and other chronic wounds. Whilst the venous ulcers segment is expected to be the primary driver of the overall market, it is worth highlighting that the global advanced wound care market for pressure ulcers segment is likely to grow at a relatively higher CAGR of 6.5%.

Currently, the Hospital Care Segment Holds the Largest Share of the Advanced Wound Care Market

Based on end users, the global market is segmented into hospital care, home / door to door services and other types of end users. Currently, the hospital care segment holds the largest market share (~50%). However, the advanced wound care market for home care / door to door services is expected to witness substantial growth in the coming years.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Currently, North America (45%) dominates the advanced wound care market and accounts for the largest revenue share.

Example Players in the Advanced Wound Care Market

3M
Arthrex
Advanced Medical Solutions
Cardinal Health
Coloplast
Convatec
DeRoyal
Ethicon
Essity
Fidia Farmaceutici
Integra Life Sciences
Medline Industries
Molnlycke Healthcare
Organogenesis
RTI Surgical
Smith+Nephew
Zimmer Biomet

ADVANCED WOUND CARE MARKET: RESEARCH COVERAGE

Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global advanced wound care market, focusing on key market segments, including [A] type of advanced wound care product, [B] type of advanced wound care dressing, [C] type of bioengineered skins and dermal substitute, [D] type of wound healing medical device, [E] type of wound treated, [F] type of acute wound treated, [G] type of chronic wound treated, [H] type of end users and [I] key geographical regions.
Advanced Wound Care Product Manufacturers Market Landscape: A comprehensive evaluation of advanced wound care companies, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of advanced wound care product, [E] type of advanced wound care dressing, [F] type of bioengineered skin and dermal substitute, [G] type of wound healing medical device, [H] type of wound treated, [I] type of acute wound treated and [J] type of chronic wound treated.
Company Competitiveness Analysis: A comprehensive competitive analysis of advanced wound care companies, examining factors, such as [A] supplier strength and [B] company competitiveness.
Company Profiles of Advance Wound Care Dressing Manufacturers: In-depth profiles of key players engaged in the development of advance wound care dressings, focusing on [A] overview of the company, [B] financial information (if available), [C] product portfolio, and [D] recent developments and [E] an informed future outlook.
Company Profiles of Bioengineered Skins and Dermal Substitute Manufacturers: In-depth profiles of key players engaged in the development of bioengineered skins and dermal substitutes, focusing on [A] overview of the company, [B] financial information (if available), [C] product portfolio, and [D] recent developments and [E] an informed future outlook.
Company Profiles of Wound Healing Medical Device Manufacturers: In-depth profiles of key players engaged in the development of wound healing medical devices, focusing on [A] overview of the company, [B] financial information (if available), [C] product portfolio, and [D] recent developments and [E] an informed future outlook.
Clinical Trial Analysis: An insightful analysis of clinical trials related to advanced wound care products, based on several parameters, such as [A] trial registration year, [B] trial phase, [C] trial status, [D] type of wound treated, [E] type of wound care product, [F] trial purpose, [G] age group, [H] type of sponsor, [I] most active player, [J] enrolled patient population, and [K] key geographical regions.
Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in the advanced wound care market, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] purpose of partnership, [D] type of partner, [E] most active players (in terms of the number of partnerships signed) and [F] geographical distribution of partnership activity.
Market Impact Analysis: A thorough analysis of various factors, such as drivers, restraints, opportunities, and existing challenges that are likely to impact market growth.

KEY QUESTIONS ANSWERED IN THIS REPORT

How many companies are currently engaged in this market?
Which are the leading companies in this market?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
15% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older

1. PREFACE

1.1. Chapter Overview
1.2. Project Objectives
1.3. Scope of the Report
1.4. Inclusions and Exclusions
1.5. Key Questions Answered
1.6. Chapter Outlines

2.RESEARCH METHODOLOGY

2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Considerations
- 2.6.1. Demographics
- 2.6.2. Economic Factors
- 2.6.3. Government Regulations
- 2.6.4. Supply Chain
- 2.6.5. COVID Impact / Related Factors
- 2.6.6. Market Access
- 2.6.7. Healthcare Policies
- 2.6.8. Industry Consolidation
2.7. Key Market Segmentations

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

3.1. Chapter Overview
3.2. Market Dynamics
- 3.2.1. Time Period
  - 3.2.1.1. Historical Trends
  - 3.2.1.2. Current and Forecasted Estimates
- 3.2.2. Currency Coverage
  - 3.2.2.1. Overview of Major Currencies Affecting the Market
  - 3.2.2.2. Impact of Currency Fluctuations on the Industry
- 3.2.3. Foreign Exchange Impact
  - 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
  - 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
- 3.2.4. Recession
  - 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
  - 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
- 3.2.5. Inflation
  - 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
  - 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

5.1. Chapter Overview
5.2. Overview of Wound Care
5.3. Types of Wounds and Injuries
- 5.3.1. Acute Wounds
- 5.3.2. Chronic Wounds
5.4. Need for Advanced Wound Care Solutions
5.5. Types of Advanced Wound Care Solutions
- 5.5.1. Wound Care Dressings
- 5.5.2. Bioengineered Skins and Dermal Substitutes
- 5.5.3. Wound Healing Medical Devices
5.6. Advantages of Advanced Wound Care Products
5.7. Future Perspectives

6. MARKET LANDSCAPE

6.1. Chapter Overview
6.2. Advanced Wound Care Product Manufacturers Landscape
- 6.2.1. Analysis by Year of Establishment
- 6.2.2. Analysis by Company Size
- 6.2.3. Analysis by Location of Headquarters (Region)
- 6.2.4. Analysis by Location of Headquarters (Country)
- 6.2.5. Analysis by Year of Establishment and Location of Headquarters
- 6.2.6. Analysis by Type of Advanced Wound Care Product
  - 6.2.6.1. Wound Care Dressing Landscape
    - 6.2.6.1.1. Analysis by Type of Wound Care Dressing
    - 6.2.6.1.2. Analysis by Type of Wound Treated
    - 6.2.6.1.3. Analysis by Type of Acute Wound Treated
    - 6.2.6.1.4. Analysis by Type of Chronic Wound Treated
  - 6.2.6.2. Bioengineered Skins and Dermal Substitutes Landscape
    - 6.2.6.2.1. Analysis by Type of Bioengineered Skin and Dermal Substitute
    - 6.2.6.2.2. Analysis by Type of Wound Treated
    - 6.2.6.2.3. Analysis by Type of Acute Wound Treated
    - 6.2.6.2.4. Analysis by Type of Chronic Wound Treated
  - 6.2.6.3. Wound Healing Medical Devices Landscape
    - 6.2.6.3.1. Analysis by Type of Wound Healing Medical Device
    - 6.2.6.3.2. Analysis by Type of Wound Treated
    - 6.2.6.3.3. Analysis Type of Acute Wound Treated
    - 6.2.6.3.4. Analysis Type of Chronic Wound Treated

7. COMPANY COMPETITIVENESS ANALYSIS

7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Company Competitiveness Analysis
- 7.4.1. Wound Care Dressing Manufacturer
  - 7.4.1.1. Players based in North America
  - 7.4.1.2. Players based in Europe
  - 7.4.1.3. Players based in Asia-Pacific and Rest of the World
- 7.4.2. Bioengineered Skins and Dermal Substitute Manufacturer
  - 7.4.2.1. Players based in North America
  - 7.4.2.2. Players based in Europe, Asia-Pacific and Rest of the World
- 7.4.3. Wound Healing Medical Device Manufacturers
  - 7.4.3.1. Players based in North America
  - 7.4.3.2. Players based in Europe, Asia-Pacific and Rest of the World

8. COMPANY PROFILES

8.1. Chapter Overview
8.2. 3M
- 8.2.1. Company Overview
- 8.2.2. Financial Information
- 8.2.3. Advanced Wound Care Portfolio
- 8.2.4. Recent Developments and Future Outlook
8.3. Coloplast
- 8.3.1. Company Overview
- 8.3.2. Financial Information
- 8.3.3. Advanced Wound Care Portfolio
- 8.3.4. Recent Developments and Future Outlook
8.4. Ethicon (a subsidiary of Johnson & Johnson)
- 8.4.1. Company Overview
- 8.4.2. Financial Information
- 8.4.3. Advanced Wound Care Portfolio
- 8.4.4. Recent Developments and Future Outlook
8.5. Fidia Farmaceutici
- 8.5.1. Company Overview
- 8.5.2. Financial Information
- 8.5.3. Advanced Wound Care Portfolio
- 8.5.4. Recent Developments and Future Outlook
8.6. Molnlycke Healthcare
- 8.6.1. Company Overview
- 8.6.2. Financial Information
- 8.6.3. Advanced Wound Care Portfolio
- 8.6.4. Recent Developments and Future Outlook
8.7. Smith+Nephew
- 8.7.1. Company Overview
- 8.7.2. Financial Information
- 8.7.3. Advanced Wound Care Portfolio
- 8.7.4. Recent Developments and Future Outlook
8.8. Zimmer Biomet
- 8.8.1. Company Overview
- 8.8.2. Financial Information
- 8.8.3. Advanced Wound Care Portfolio
- 8.8.4. Recent Developments and Future Outlook
8.9. Other Leading Players
- 8.9.1. Advanced Medical Solutions
  - 8.9.1.1. Company Overview
  - 8.9.1.2. Advanced Wound Care Portfolio
- 8.9.2. Arthrex
  - 8.9.2.1. Company Overview
  - 8.9.2.2. Advanced Wound Care Portfolio
- 8.9.3. Cardinal Health
  - 8.9.3.1. Company Overview
  - 8.9.3.2. Advanced Wound Care Portfolio
- 8.9.4. Convatec
  - 8.9.4.1. Company Overview
  - 8.9.4.2. Advanced Wound Care Portfolio
- 8.9.5. DeRoyal
  - 8.9.5.1. Company Overview
  - 8.9.5.2. Advanced Wound Care Portfolio
- 8.9.6. Essity
  - 8.9.6.1. Company Overview
  - 8.9.6.2. Advanced Wound Care Portfolio
- 8.9.7. Integral Life Sciences
  - 8.9.7.1. Company Overview
  - 8.9.7.2. Advanced Wound Care Portfolio
- 8.9.8. Medline Industries
  - 8.9.8.1. Company Overview
  - 8.9.8.2. Advanced Wound Care Portfolio
- 8.9.9. Organogenesis
  - 8.9.9.1. Company Overview
  - 8.9.9.2. Advanced Wound Care Portfolio
- 8.9.10. RTI Surgical
  - 8.9.10.1. Company Overview
  - 8.9.10.2. Advanced Wound Care Portfolio

9. CLINICAL TRIAL ANALYSIS

9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Advanced Wound Care: Clinical Trial Analysis
- 9.3.1. Analysis by Trial Registration Year
  - 9.3.1.1. Analysis by Trial Registration Year and Enrolled Patient Population
- 9.3.2. Analysis by Trial Phase
  - 9.3.2.1. Analysis by Trial Phase and Enrolled Patient Population
- 9.3.3. Analysis by Trial Status
  - 9.3.3.1. Analysis by Trial Status and Enrolled Patient Population
- 9.3.4. Analysis by Type of Wound Treated
- 9.3.5. Analysis by Type of Wound Care Product
- 9.3.6. Analysis by Trial Focus Area
- 9.3.7. Analysis by Age Group of Enrolled Patients
- 9.3.8. Analysis by Type of Sponsor / Collaborator
- 9.3.9. Most Active Player: Analysis by Number of Trials
- 9.3.10. Analysis by Geography
- 9.3.11. Analysis by Trial Registration Year and Geography
- 9.3.12. Analysis by Geography and Enrolled Patient Population

10. PARTNERSHIPS AND COLLABORATIONS

10.1. Chapter Overview
10.2. Partnership Models
10.3. Advanced Wound Care: Partnerships and Collaborations
- 10.3.1. Analysis by Year of Partnership
- 10.3.2. Analysis by Type of Partnership
- 10.3.3. Analysis by Year and Type of Partnership
- 10.3.4. Analysis by Purpose of Partnership
- 10.3.5. Analysis by Type of Partner
- 10.3.6. Analysis by Year of Partnership and Type of Partner
- 10.3.7. Most Active Player: Analysis by Number of Partnerships
- 10.3.8. Analysis by Geography
  - 10.3.8.1. Local and International Agreements
  - 10.3.8.2. Intracontinental and Intercontinental Agreements

11. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

11.1. Chapter Overview
11.2. Market Drivers
11.3. Market Restraints
11.4. Market Opportunities
11.5. Market Challenges
11.6. Conclusion

12. GLOBAL ADVANCED WOUND CARE MARKET

12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Global Advanced Wound Care Market, Historical Trend (Since 2019) and Forecasted Estimates (Till 2035)
- 12.3.1. Scenario Analysis
  - 12.3.1.1. Conservative Scenario
  - 12.3.1.2. Optimistic Scenario
12.4. Key Market Segmentations

13. GLOBAL ADVANCED WOUND CARE MARKET, BY TYPE OF ADVANCED WOUND CARE PRODUCT

13.1. Chapter Overview
13.2. Key Assumptions and Forecast Methodology
13.3. Advanced Wound Care Market: Distribution by Type of Advanced Wound Care Product
- 13.3.1. Advanced Wound Care Market for Wound Care Dressings: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
- 13.3.2. Advanced Wound Care Market for Bioengineered Skins and Dermal Substitutes: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
- 13.3.3. Advanced Wound Care Market for Wound Healing Medical Devices: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.4. Data Triangulation and Validation

14. ADVANCED WOUND CARE MARKET, BY TYPE OF WOUND CARE DRESSING

14.1. Chapter Overview
14.2. Key Assumptions and Forecast Methodology
14.3. Advanced Wound Care Market: Distribution by Type of Wound Care Dressing
- 14.3.1. Advanced Wound Care Market for Foam Dressings: Forecasted Estimates (Till 2035)
- 14.3.2. Advanced Wound Care Market for Antimicrobial Dressings: Forecasted Estimates (Till 2035)
- 14.3.3. Advanced Wound Care Market for Alginate Dressings: Forecasted Estimates (Till 2035)
- 14.3.4. Advanced Wound Care Market for Hydrogel Dressings: Forecasted Estimates (Till 2035)
- 14.3.5. Advanced Wound Care Market for Hydrocolloid Dressings: Forecasted Estimates (Till 2035)
- 14.3.6. Advanced Wound Care Market for Composite Dressings: Forecasted Estimates (Till 2035)
- 14.3.7. Advanced Wound Care Market for Other Types of Wound Care Dressings: Forecasted Estimates (Till 2035)
14.4. Data Triangulation and Validation

15. ADVANCED WOUND CARE MARKET, BY BIOENGINEERED SKINS AND DERMAL SUBSTITUTE

15.1. Chapter Overview
15.2. Key Assumptions and Forecast Methodology
15.3. Advanced Wound Care Market: Distribution by Type of Bioengineered Skin and Dermal Substitute
- 15.3.1. Advanced Wound Care Market for Allografts: Forecasted Estimates (Till 2035)
- 15.3.2. Advanced Wound Care Market for Autografts: Forecasted Estimates (Till 2035)
- 15.3.3. Advanced Wound Care Market for Extracellular Matrices: Forecasted Estimates (Till 2035)
- 15.3.4. Advanced Wound Care Market for Growth Factors: Historical Trends (Forecasted Estimates (Till 2035)
- 15.3.5. Advanced Wound Care Market for Other Dermal Substitutes: Forecasted Estimates (Till 2035)
15.4. Data Triangulation and Validation

16. ADVANCED WOUND CARE MARKET: DISTRIBUTION BY TYPE OF WOUND HEALING MEDICAL DEVICE

16.1. Chapter Overview
16.2. Key Assumptions and Forecast Methodology
16.3. Advanced Wound Care Market: Distribution by Type of Wound Healing Medical Device
- 16.3.1. Advanced Wound Care Market for Negative Pressure Wound Therapy: Forecasted Estimates (Till 2035)
- 16.3.2. Advanced Wound Care Market for Hyperbaric Oxygen Therapy: Forecasted Estimates (Till 2035)
- 16.3.3. Advanced Wound Care Market for Topical Oxygen Therapy: Forecasted Estimates (Till 2035)
- 16.3.4. Advanced Wound Care Market for Hydrotherapy: Forecasted Estimates (Till 2035)
- 16.3.5. Advanced Wound Care Market for Electric Stimulation Therapy: Forecasted Estimates (Till 2035)
- 16.3.6. Advanced Wound Care Market for Skin Closure Systems / Adhesives: Forecasted Estimates (Till 2035)
- 16.3.7. Advanced Wound Care Market for Other Types of Wound Healing Medical Devices: Forecasted Estimates (Till 2035)
16.4. Data Triangulation and Validation

17. ADVANCED WOUND CARE MARKET, BY TYPE OF WOUND TREATED

17.1. Chapter Overview
17.2. Key Assumptions and Forecast Methodology
17.3. Advanced Wound Care Market: Distribution by Type of Wound Treated
- 17.3.1. Advanced Wound Care Market for Acute Wounds: Forecasted Estimates (Till 2035)
- 17.3.2. Advanced Wound Care Market for Chronic Wounds: Forecasted Estimated (Till 2035)
17.4. Data Triangulation and Validation

18. ADVANCED WOUND CARE MARKET, BY TYPE OF ACUTE WOUND TREATED

18.1. Chapter Overview
18.2. Key Assumptions and Forecast Methodology
18.3. Advanced Wound Care Market: Distribution by Types of Acute Wound Treated
- 18.3.1. Advanced Wound Care Market for Surgical Wounds: Forecasted Estimates (Till 2035)
- 18.3.2. Advanced Wound Care Market for Burns: Forecasted Estimated (Till 2035)
- 18.3.3. Advanced Wound Care Market for Other Types of Acute Wounds: Forecasted Estimated (Till 2035)
18.4. Data Triangulation and Validation

19. ADVANCED WOUND CARE MARKET, BY TYPE OF CHRONIC WOUND TREATED

19.1. Chapter Overview
19.2. Key Assumptions and Forecast Methodology
19.3. Advanced Wound Care Market: Distribution by Type Chronic Wound Treated
- 19.3.1. Advanced Wound Care Market for Diabetic Ulcers: Forecasted Estimates (Till 2035)
- 19.3.2. Advanced Wound Care Market for Venous Ulcers: Forecasted Estimated (Till 2035)
- 19.3.3. Advanced Wound Care Market for Pressure Ulcers: Forecasted Estimated (Till 2035)
- 19.3.4. Advanced Wound Care Market for Other Types of Chronic Wounds: Forecasted Estimated (Till 2035)
19.4. Data Triangulation and Validation

20. ADVANCED WOUND CARE MARKET, BY TYPE OF END USER

20.1. Chapter Overview
20.2. Key Assumptions and Forecast Methodology
20.3. Advanced Wound Care Market: Distribution by Type of End User
- 20.3.1. Advanced Wound Care Market for Hospital Care: Forecasted Estimates (Till 2035)
- 20.3.2. Advanced Wound Care Market for Home Care / Door to Door Services: Forecasted Estimates (Till 2035)
- 20.3.3. Advanced Wound Care Market for Other Types of End Users: Forecasted Estimates (Till 2035)
20.4. Data Triangulation and Validation

21. ADVANCED WOUND CARE MARKET, BY KEY GEOGRAPHICAL REGIONS

21.1. Chapter Overview
21.2. Key Assumptions and Forecast Methodology
21.3. Advanced Wound Care Market: Distribution by Key Geographical Regions
- 21.3.1. Advanced Wound Care Market in North America: Forecasted Estimates (Till 2035)
  - 21.3.1.1. Advanced Wound Care Market in the US: Forecasted Estimates (Till 2035)
  - 21.3.1.2. Advanced Wound Care Market Canada: Forecasted Estimates (Till 2035)
- 21.3.2. Advanced Wound Care Market in Europe: Forecasted Estimates (Till 2035)
  - 21.3.2.1. Advanced Wound Care Market in Germany: Forecasted Estimates (Till 2035)
  - 21.3.2.2. Advanced Wound Care Market in France: Forecasted Estimates (Till 2035)
  - 21.3.2.3. Advanced Wound Care Market in the UK: Forecasted Estimates (Till 2035)
  - 21.3.2.4. Advanced Wound Care Market in Spain: Forecasted Estimates (Till 2035)
  - 21.3.2.5. Advanced Wound Care Market in Italy: Forecasted Estimates (Till 2035)
- 21.3.3. Advanced Wound Care Market in Asia-Pacific and Rest of the World: Forecasted Estimates (Till 2035)
  - 21.3.3.1. Advanced Wound Care Market in China: Forecasted Estimates (Till 2035)
  - 21.3.3.2. Advanced Wound Care Market in Japan: Forecasted Estimates (Till 2035)
  - 21.3.3.3. Advanced Wound Care Market in Brazil: Forecasted Estimates (Till 2035)
  - 21.3.3.4. Advanced Wound Care Market in Australia: Forecasted Estimates (Till 2035)
  - 21.3.3.5. Advanced Wound Care Market in South Korea: Forecasted Estimates (Till 2035)
  - 21.3.3.6. Advanced Wound Care Market in Israel: Forecasted Estimates (Till 2035)
21.4. Data Triangulation and Validation

Advanced Wound Care Market Distribution by Type of Advanced Wound Care Product, Type of Advanced Wound Care Dressing, Type of Wound Healing Medical Device, Type of End User and Key Geographical Regions

先進創傷治療市場：成長と動向

先進創傷治療市場：主要インサイト

先進創傷治療市場：主要セグメント

目次

第1章 序文

第2章 調査手法

第3章 経済的およびその他のプロジェクト特有の考慮事項

第4章 エグゼクティブサマリー

第5章 イントロダクション

第6章 市場情勢

第7章 企業競争力分析

第8章 企業プロファイル

第9章 臨床試験の分析

第10章 パートナーシップとコラボレーション

第11章 市場影響分析：促進要因、抑制要因、機会、課題

第12章 世界の先進創傷治療市場

第13章 世界の先進創傷治療市場（先進創傷治療製品タイプ別）

第14章 世界の先進創傷治療市場（先進創傷治療創傷被覆材タイプ別）

第15章 世界の先進創傷治療市場（バイオエンジニアリング皮膚・真皮代替物タイプ別）

第16章 世界の先進創傷治療市場（創傷治癒医療機器タイプ別）

第17章 世界の先進創傷治療市場（創傷治療タイプ別）

第18章 世界の先進創傷治療市場（治療対象の急性創傷タイプ別）

第19章 世界の先進創傷治療市場（治療対象の慢性創傷タイプ別）

第20章 世界の先進創傷治療市場（エンドユーザー別）

第21章 世界の先進創傷治療市場（主要地域別）

第22章 結論

第23章 付録1：表形式データ

第24章 付録2：企業・団体一覧

List of Tables

List of Figures

ADVANCED WOUND CARE MARKET: OVERVIEW

ADVANCED WOUND CARE MARKET: GROWTH AND TRENDS

ADVANCED WOUND CARE MARKET: KEY INSIGHTS

ADVANCED WOUND CARE MARKET: KEY SEGMENTS

Example Players in the Advanced Wound Care Market

ADVANCED WOUND CARE MARKET: RESEARCH COVERAGE

KEY QUESTIONS ANSWERED IN THIS REPORT

REASONS TO BUY THIS REPORT

ADDITIONAL BENEFITS

TABLE OF CONTENTS

1. PREFACE

2.RESEARCH METHODOLOGY

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

4. EXECUTIVE SUMMARY

5. INTRODUCTION

6. MARKET LANDSCAPE

7. COMPANY COMPETITIVENESS ANALYSIS

8. COMPANY PROFILES

9. CLINICAL TRIAL ANALYSIS

10. PARTNERSHIPS AND COLLABORATIONS

11. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

12. GLOBAL ADVANCED WOUND CARE MARKET

13. GLOBAL ADVANCED WOUND CARE MARKET, BY TYPE OF ADVANCED WOUND CARE PRODUCT

14. ADVANCED WOUND CARE MARKET, BY TYPE OF WOUND CARE DRESSING

15. ADVANCED WOUND CARE MARKET, BY BIOENGINEERED SKINS AND DERMAL SUBSTITUTE

16. ADVANCED WOUND CARE MARKET: DISTRIBUTION BY TYPE OF WOUND HEALING MEDICAL DEVICE

17. ADVANCED WOUND CARE MARKET, BY TYPE OF WOUND TREATED

18. ADVANCED WOUND CARE MARKET, BY TYPE OF ACUTE WOUND TREATED

19. ADVANCED WOUND CARE MARKET, BY TYPE OF CHRONIC WOUND TREATED

20. ADVANCED WOUND CARE MARKET, BY TYPE OF END USER

21. ADVANCED WOUND CARE MARKET, BY KEY GEOGRAPHICAL REGIONS

22. CONCLUSION

23. APPENDIX 1: TABULATED DATA

24. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

第1章序文

第2章調査手法

第3章経済的およびその他のプロジェクト特有の考慮事項

第4章エグゼクティブサマリー

第5章イントロダクション

第6章市場情勢

第7章企業競争力分析

第8章企業プロファイル

第9章臨床試験の分析

第10章パートナーシップとコラボレーション

第11章市場影響分析：促進要因、抑制要因、機会、課題

第12章世界の先進創傷治療市場

第13章世界の先進創傷治療市場（先進創傷治療製品タイプ別）

第14章世界の先進創傷治療市場（先進創傷治療創傷被覆材タイプ別）

第15章世界の先進創傷治療市場（バイオエンジニアリング皮膚・真皮代替物タイプ別）

第16章世界の先進創傷治療市場（創傷治癒医療機器タイプ別）

第17章世界の先進創傷治療市場（創傷治療タイプ別）

第18章世界の先進創傷治療市場（治療対象の急性創傷タイプ別）

第19章世界の先進創傷治療市場（治療対象の慢性創傷タイプ別）

第20章世界の先進創傷治療市場（エンドユーザー別）

第21章世界の先進創傷治療市場（主要地域別）

第22章結論

第23章付録1：表形式データ

第24章付録2：企業・団体一覧